Log In
Print
BCIQ
Print
Print this Print this
 

BCT-100

  Manage Alerts
Collapse Summary General Information
Company Bio-Cancer Treatment International Ltd.
DescriptionRecombinant human arginase in phosphate saline buffer
Molecular Target
Mechanism of Action 
Therapeutic ModalityBiologic: Enzyme
Latest Stage of DevelopmentPhase I/II
Standard IndicationLiver cancer
Indication DetailsTreat advanced hepatocellular carcinoma (HCC); Treat metastatic hepatocellular carcinoma (HCC)
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today